David Patience, CFO at Accelerate Diagnostics, holds 275.76K shares in TriSalus Life Sciences (Ticker: TLSI), holds 65.33K shares in Accelerate Diagnostics (Ticker: AXDXQ). Most recently, David Patience Bought ― shares of TriSalus Life Sciences on May 18, 2026 for an estimated value of $17.25K.
What is the percentage of profitable transactions made by David Patience?
The percentage of profitable transactions made by David Patience is 50%.
What is the average return per transaction made by David Patience?
The average return per transaction made by David Patience is -9.50%.
What stocks does David Patience hold?
David Patience holds: AXDXQ, TLSI stocks.
What was David Patience’s latest transaction?
David Patience latest transaction was an Informative Buy of $17.25K.
What was David Patience's most profitable transaction?
David Patience’s most profitable transaction was an Informative Buy of TLSI stock on May 18, 2026. The return on the trade was 12.50%.
What is David Patience's role in Accelerate Diagnostics?
David Patience's role in Accelerate Diagnostics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.